Literature DB >> 26418282

On analysis of longitudinal clinical trials with missing data using reference-based imputation.

G Frank Liu1, Lei Pang1.   

Abstract

Reference-based imputation (RBI) methods have been proposed as sensitivity analyses for longitudinal clinical trials with missing data. The RBI methods multiply impute the missing data in treatment group based on an imputation model built using data from the reference (control) group. The RBI will yield a conservative treatment effect estimate as compared to the estimate obtained from multiple imputation (MI) under missing at random (MAR). However, the RBI analysis based on the regular MI approach can be overly conservative because it not only applies discount to treatment effect estimate but also posts penalty on the variance estimate. In this article, we investigate the statistical properties of RBI methods, and propose approaches to derive accurate variance estimates using both frequentist and Bayesian methods for the RBI analysis. Results from simulation studies and applications to longitudinal clinical trial datasets are presented.

Keywords:  Bayesian MCMC; longitudinal clinical trial; missing data; reference-based imputation; sensitivity analysis

Mesh:

Year:  2015        PMID: 26418282     DOI: 10.1080/10543406.2015.1094810

Source DB:  PubMed          Journal:  J Biopharm Stat        ISSN: 1054-3406            Impact factor:   1.051


  7 in total

1.  SMIM: A unified framework of survival sensitivity analysis using multiple imputation and martingale.

Authors:  Shu Yang; Yilong Zhang; Guanghan Frank Liu; Qian Guan
Journal:  Biometrics       Date:  2021-08-27       Impact factor: 2.571

2.  Efficient Multiple Imputation for Sensitivity Analysis of Recurrent Events Data with Informative Censoring.

Authors:  Guoqing Diao; Guanghan F Liu; Donglin Zeng; Yilong Zhang; Gregory Golm; Joseph F Heyse; Joseph G Ibrahim
Journal:  Stat Biopharm Res       Date:  2020-11-05       Impact factor: 1.586

Review 3.  A narrative review of estimands in drug development and regulatory evaluation: old wine in new barrels?

Authors:  M Mitroiu; K Oude Rengerink; S Teerenstra; F Pétavy; K C B Roes
Journal:  Trials       Date:  2020-07-23       Impact factor: 2.279

4.  Information-anchored sensitivity analysis: theory and application.

Authors:  Suzie Cro; James R Carpenter; Michael G Kenward
Journal:  J R Stat Soc Ser A Stat Soc       Date:  2018-11-16       Impact factor: 2.483

5.  Repeated measures ASCA+ for analysis of longitudinal intervention studies with multivariate outcome data.

Authors:  Torfinn S Madssen; Guro F Giskeødegård; Age K Smilde; Johan A Westerhuis
Journal:  PLoS Comput Biol       Date:  2021-11-09       Impact factor: 4.475

6.  Estimation of treatment effects in short-term depression studies. An evaluation based on the ICH E9(R1) estimands framework.

Authors:  Marian Mitroiu; Steven Teerenstra; Katrien Oude Rengerink; Frank Pétavy; Kit C B Roes
Journal:  Pharm Stat       Date:  2022-06-09       Impact factor: 1.234

7.  A causal modelling framework for reference-based imputation and tipping point analysis in clinical trials with quantitative outcome.

Authors:  Ian R White; Royes Joseph; Nicky Best
Journal:  J Biopharm Stat       Date:  2019-11-12       Impact factor: 1.051

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.